StockVS

Columbus Circle Capital Corp II (CMII) Stock Analysis

Financial Services

Columbus Circle Capital Corp II

$9.91

+$0.01 (+0.10%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Columbus Circle Capital Corp II operates as a financial entity with a current market capitalization of $307.83 million, indicating a substantial valuation within the financial services landscape despite the absence of detailed business descriptions or industry classifications in the available data. The company's sector and industry are not explicitly defined in the provided records, which limits the ability to contextualize its specific operational niche relative to broader market peers or to determine the competitive dynamics of its specific vertical. The organization employs an undefined number of staff, a metric that is currently listed as N/A, suggesting either a highly automated structure or a lack of public disclosure regarding human capital allocation. Given the market cap of $307.83 million, the firm occupies a significant position in the capital markets, yet the lack of revenue and employee data prevents a precise assessment of its operational scale or efficiency relative to the size of its enterprise value.

Financial Health

The available financial records indicate that the trailing twelve-month revenue, net income, and EBITDA figures are not publicly disclosed or are listed as N/A, which obscures the traditional analysis of the gap between top-line revenue and bottom-line profitability that usually reveals a company's cost structure and operational leverage. Similarly, the free cash flow generation is not specified in the provided facts, making it impossible to quantify the company's financial flexibility or its ability to fund internal growth projects, acquisitions, or debt servicing without external cash sources. The gross margin, operating margin, and profit margin are all absent from the dataset, preventing an evaluation of how effectively the company converts sales into profit at each stage of the production or service delivery process. Regarding liquidity and leverage, the total cash on hand and total debt obligations are both listed as N/A, while the debt-to-equity ratio is also unavailable, which collectively hinders an assessment of whether the balance sheet is conservative or leveraged. The current ratio, a key indicator of short-term liquidity, is not provided, leaving the ability to meet short-term obligations with short-term assets indeterminate. Furthermore, the return on equity and return on assets metrics are missing, which prevents any determination of how effectively management is utilizing shareholder capital and total assets to generate returns.

Valuation Assessment

The trailing P/E ratio and forward P/E ratio are both listed as N/A in the available facts, which precludes any analysis of the difference between them or what such a difference might imply about the expected earnings trajectory for the coming year. The price-to-book ratio stands at 9825.00, a figure that indicates an extreme market premium over the company's book value, suggesting that the market values the firm at nearly 10,000 times its net asset book value, a metric that is highly unusual and warrants scrutiny. The price-to-sales ratio and EV/EBITDA are also not available in the current data, limiting the ability to use these alternative valuation metrics to cross-reference the stock's expensive valuation against its sales volume or earnings power. The 52-week high is recorded at $9.95 and the 52-week low at $9.76, placing the current trading price in an extremely narrow range where the stock is trading only a fraction of a percent below the 52-week high and just a fraction above the 52-week low. The beta value is listed as N/A, meaning that the stock's price volatility relative to the broader market cannot be calculated from the provided information, leaving the risk profile relative to the market index undefined.

Growth & Income

The revenue growth year-over-year and earnings growth year-over-year rates are both listed as N/A, preventing any comparison between the speed of earnings growth versus revenue growth or insights into whether the company is expanding its top line faster than its profits. Since the dividend yield and payout ratio are not provided in the facts, it is impossible to state whether the company pays dividends or to evaluate the sustainability of any payout ratio given the company's earnings. In the absence of dividend data, the company appears to follow a profile where earnings are either reinvested into growth or retained rather than distributed to shareholders, a common characteristic for certain capital structures or early-stage entities. Overall, the growth and income profile of Columbus Circle Capital Corp II remains opaque due to the lack of revenue growth, earnings growth, and dividend yield data, resulting in a picture where the company's trajectory for expansion and shareholder return is not quantifiable from the available metrics.

Peer Comparison

Columbus Circle Capital Corp II (CMII) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Columbus Circle Capital Corp II CMII $310.50M N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

The Shell Companies industry average P/E ratio is 82.8x. Columbus Circle Capital Corp II trades at a P/E of N/A.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Columbus Circle Capital Corp II

Columbus Circle Capital Corp II does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in New York, New York.

Key Statistics

Market Cap
$310.50M
P/E Ratio
N/A
52-Week High
$9.95
52-Week Low
$9.76
Avg Volume
44.43K

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
United States